NZ239308A - Process for producing solid oral dosage forms of loperamide and dosage forms thus formed - Google Patents

Process for producing solid oral dosage forms of loperamide and dosage forms thus formed

Info

Publication number
NZ239308A
NZ239308A NZ239308A NZ23930891A NZ239308A NZ 239308 A NZ239308 A NZ 239308A NZ 239308 A NZ239308 A NZ 239308A NZ 23930891 A NZ23930891 A NZ 23930891A NZ 239308 A NZ239308 A NZ 239308A
Authority
NZ
New Zealand
Prior art keywords
loperamide
solid oral
dosage form
compound
oral dosage
Prior art date
Application number
NZ239308A
Other languages
English (en)
Inventor
Daniel Louis Barone
Shawn Alan Denny
Francis Bernard Chapura
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of NZ239308A publication Critical patent/NZ239308A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NZ239308A 1990-08-09 1991-08-08 Process for producing solid oral dosage forms of loperamide and dosage forms thus formed NZ239308A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56501090A 1990-08-09 1990-08-09

Publications (1)

Publication Number Publication Date
NZ239308A true NZ239308A (en) 1994-04-27

Family

ID=24256836

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ239308A NZ239308A (en) 1990-08-09 1991-08-08 Process for producing solid oral dosage forms of loperamide and dosage forms thus formed

Country Status (9)

Country Link
EP (1) EP0542879A1 (fr)
JP (1) JPH06500104A (fr)
AU (1) AU661972B2 (fr)
CA (1) CA2088273C (fr)
FI (1) FI930536A0 (fr)
IE (1) IE912815A1 (fr)
NZ (1) NZ239308A (fr)
PT (1) PT98612A (fr)
WO (1) WO1992002223A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005117834A1 (fr) * 2004-05-27 2005-12-15 Janssen Pharmaceutica N.V. Dispersions solides d'un compose medicamenteux basique et d'un polymere renfermant des groupes acides
US10508373B2 (en) 2016-05-13 2019-12-17 Nike, Inc. Embroidered article

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1332236C (fr) * 1985-10-11 1994-10-04 Lourens Wals N-oxydes d'–-–-diaryl-4-aryl-4-hydroxy-1-piperidinebutanamide
DE3906779A1 (de) * 1989-03-03 1990-09-06 Hoechst Ag Mittel gegen tierparasiten
GB8908361D0 (en) * 1989-04-13 1989-06-01 Beecham Group Plc Composition
NZ233403A (en) * 1989-04-28 1992-09-25 Mcneil Ppc Inc Simulated capsule-like medicament

Also Published As

Publication number Publication date
IE912815A1 (en) 1992-02-12
FI930536A (fi) 1993-02-08
EP0542879A1 (fr) 1993-05-26
PT98612A (pt) 1992-06-30
CA2088273C (fr) 1996-05-14
AU8440091A (en) 1992-03-02
CA2088273A1 (fr) 1992-02-10
FI930536A0 (fi) 1993-02-08
JPH06500104A (ja) 1994-01-06
WO1992002223A1 (fr) 1992-02-20
AU661972B2 (en) 1995-08-17

Similar Documents

Publication Publication Date Title
FI122717B (fi) Menetelmä valmistaa tramadolihydrokloridia hallitusti vapauttava valmiste
JP6797980B2 (ja) ルカパリブの高投与力価錠剤
DE69902893T2 (de) Schnellauflösende efavirenz-kapseln oder tabletten durch verwendung von super-zersetzern
EP0108218A2 (fr) Forme de dosage orale solide à libération constante de composés pharmaceutiques très solubles dans l'eau
DE69418252T2 (de) Stabilisierte, feste pharmazeutische Zubereitung, die Dextromethorphan Phenylpropanolamine und Coffein enthält
US6558704B1 (en) Process for preparing pellets containing up to 90 wt.% of a pharmaceutical active ingredient
KR100836960B1 (ko) 새로운 나이아신 제어방출형 제제
SK76394A3 (en) Agent with successive release of effective matter and method of its preparation
EP1886670A1 (fr) Compositions pharmaceutiques de memantine
HUE028204T2 (en) Pharmaceutical compositions containing the active ingredient nilotinib or a salt thereof
IE72095B1 (en) Antimalarial compositions
WO2021238978A1 (fr) Composition pharmaceutique contenant un promédicament de nitroxoline, méthode de préparation et application de celle-ci
WO2006123213A1 (fr) Preparations a liberation modifiee de gliclazide
DE4310963C2 (de) Retardmikrotablette von beta-Phenylpropiophenonderivaten
CA2088273C (fr) Procedes pour la formulation de composes a base de loperamide sous forme posologique orale solide
CN105395507A (zh) 一种盐酸环苯扎林缓释片
EP1490034B1 (fr) Nouvelles compositions pharmaceutiques pour une combinaison antihistaminique-decongestive et procede de fabrication de ces compositions
CN1172429A (zh) 使用从高等植物中可得到的粉末状水解胶体树胶的持续释放药物运送体系
CN113365611A (zh) 制备包含奈福泮和对乙酰氨基酚的药物组合物的方法和由该方法获得的药物组合物
AU2004263054B2 (en) Preparing method for controlled released type tablet tamsulosin HCl and the tablet thereof
JPH06157606A (ja) グリコサミノグリカンとアミノ酸エステルとの塩、その製造法およびそれを含有する薬学的製剤
Fleishaker et al. Effect of food on the bioavailability of adinazolam from a sustained release formulation: effect of meal timing and lack of dose dumping
RU2183116C1 (ru) Фармацевтическая композиция, обладающая болеутоляющим, противовоспалительным, антипиретическим и спазмолитическим действием
Perumal The Preparation and In-vitro Evaluation of Sustained Release Capsules of Rivastigmine Tartrate
CN1476841A (zh) 葛根素分散片组合物及其制备方法